Medindia
Medindia LOGIN REGISTER
Advertisement

Finn Partners Launches New Global Specialty Dedicated to Pharma, Health and CSR: "Health and Social Impact"

Wednesday, September 13, 2017 Drug News
Advertisement
Collaboration Combines Health and CSR & Social Impact Practice Expertise; Taps Global Talent in Digital, Editorial, Issues, Media, Policy, Reputation, Research and Science
Advertisement

NEW YORK, Sept. 13, 2017 /PRNewswire/ -- Finn Partners, a global marketing and communications agency, today launched its "Health and Social Impact" specialty group to develop regional, national and global corporate social responsibility (CSR) campaigns for the health sector. The team is led by Amy Terpeluk, senior partner, CSR & Social Impact, and guided by Finn Partners Health Practice managing partner Gil Bashe. "Health and Social Impact" is already engaged across numerous client assignments in cancer, mental health, nutrition and women's health advocacy.   
Advertisement

"Finn Partners is a leader in creating issues-focused national and regional social movements for corporations, nonprofits, government agencies and non-government organizations, that improve human health and have sustainable impact," said Ms. Terpeluk. "Whether working in Japan, Eastern Europe and North Africa, or in Texas and Tennessee, our goal is to marshal our CSR expertise to help biotech, pharma and health companies make a societal impact. This allows us to break through the crowded media landscape, engage consumers, and strengthen brand reputations."   

Finn Partners CSR & Social Impact Practice has created award-winning and life-changing movements that bring underserved health issues to the forefront of conversations with broad support from industry, governments and NGOs, and academic leaders. Among its iconic campaigns:

  • Let's Win for Pancreatic Cancer, supported by the Lustgarten Foundation, recently selected as a PRNews Platinum All-Star Campaign;
  • No More campaign launched in 2013, uniting a diverse, global community to help end domestic violence, sexual assault and abuse;
  • Penn State THON, a student-led fundraising effort for pediatric cancer; and
  • Operation Smile, the non-profit organization that brings free cleft palate surgery to children worldwide.
"When health executives speak to issues outside day-to-day business interests, the world takes notice," said Mr. Bashe. "It's time for pharma to take its rightful place alongside major consumer product, finance and technology companies, as leaders who convey how ideas, expertise and abilities can fuel needed change. Our Health team has been instrumental in working with C-suite pharma leaders to define their executive narrative, and our CSR team is a noted industry leader in amplifying social impact. By combining our expertise, we can turn memorable moments into powerful movements," he added.

Ms. Terpeluk, who has worked closely with Mr. Bashe on global health initiatives, was selected by PRWeek as one of its 40 Under 40 PR pros. Her expertise spans product launches, cause marketing programs, social awareness campaigns, and issues/crisis management in the U.S. and globally.

Dena Merriam, a Finn Partners co-founding managing partner and one of the creators of the firm's CSR discipline, remarked, "By helping our clients articulate their solutions in addressing vital social and health-related issues, Finn Partners is helping shape global conversations about improving the human condition. Forming a CSR/Health specialty is a natural progression, drawing on the talents of these Finn Partners practices that are committed to making a difference in the world."

About Finn Partners

Founded in 2011 on the core principles of innovation and collaborative partnership, Finn Partners has more than tripled in size in just five and a half years, becoming one of the fastest growing independent public relations agencies in the world. The full-service marketing and communications company's record-setting pace is a result of organic growth and integrating new companies and new people into the Finn Partners world through a common philosophy. With 550 professionals, Finn Partners provides its clients with global access and capabilities in the U.S., Europe and Asia, in addition to PROI Worldwide. Headquartered in New York, Finn Partners' other offices are located in Chicago, Detroit, Fort Lauderdale, Jerusalem, London, Los Angeles, Munich, Nashville, Paris, Portland, San Francisco, Singapore and Washington D.C. Find us at finnpartners.com and follow us on Twitter and Instagram at @finnpartners.

Contact:[email protected]212-715-1600

View original content:http://www.prnewswire.com/news-releases/finn-partners-launches-new-global-specialty-dedicated-to-pharma-health-and-csr-health-and-social-impact-300518732.html

SOURCE Finn Partners, Inc.

Sponsored Post and Backlink Submission


Latest Press Release on Drug News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close